Skip to content

Gum-disease review ranks drug–fibrin combinations but leaves benefit size unclear

A network analysis favored some medicine–fibrin combinations for periodontal repair, but its abstract reports rankings without the size or precision of treatment differences.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

In this network comparison, adding metformin to platelet-rich fibrin received the highest rank for attachment gain. Alendronate and rosuvastatin combinations also ranked favorably, particularly for bone fill. However, treatment rankings do not show how much patients improved, and the abstract provides no effect estimates with uncertainty to judge those differences.

Keep in mind

The abstract supplies rankings without absolute differences or confidence intervals. Follow-up is limited to the reported study periods, and the authors call for larger trials with longer observation.

THE RESULT, WITH CONTEXT

What researchers found

Metformin combination ranked highest

Clinical attachment level gain

SUCRA ranking of metformin plus platelet-rich fibrin against other combinations, fibrin alone and placebo; included follow-up periods were 6 and 9 months.

BMC Oral Health, 2026 · Original source ↓

What the outcomes describe

The review compared combinations of platelet-rich fibrin and medicines using a network meta-analysis. Its main outcomes were attachment gain and bone fill, which describe periodontal repair rather than whether teeth were retained.

How to read a ranking

SUCRA summarizes how treatments rank within a comparison network. A high rank does not show the size of improvement or the certainty of a head-to-head advantage; those details are missing from this abstract.

CHECK THE ORIGINAL

The original publication

A network meta-analysis of randomized controlled trials evaluating the evidence of pharmacological agents and growth factors in the regeneration of bony defects in chronic periodontitis.

Koli S, Rathod S, Kolte A et al.
BMC Oral Health · 2026

PubMed ID
41634685
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.